Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Cell. Infect. Microbiol.

Sec. Veterinary and Zoonotic Infection

Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1653170

This article is part of the Research TopicUnveiling Host-Pathogen Interactions: Insights into Animal Cellular Immunity and Novel Diagnostics - Volume IIView all 15 articles

Construction of an EGFP-Embedded Porcine Reproductive and Respiratory Syndrome Virus Infectious Clone and Antiviral Drug Screening

Provisionally accepted
Rongxiao  LiuRongxiao LiuShi  FuShi FuChai  YukunChai YukunNian  LiuNian LiuLiu  BenjinLiu BenjinLuo  LingzhiLuo LingzhiYang  WeiYang Wei*Dong  XiumeiDong Xiumei*Jin  CuiJin Cui*
  • Northeast Agricultural University, Harbin, China

The final, formatted version of the article will be published soon.

Porcine reproductive and respiratory syndrome virus (PRRSV) is a significant pathogen posed a serious threat to the global swine industry. In this study, a BAC-based reverse genetics platform was established using a highly pathogenic PRRSV (HP-PRRSV) strain. Three recombinant reporter viruses were constructed by inserting the enhanced green fluorescent protein (EGFP) gene into three different intergenic regions of the complete PRRSV-L251 genome. Immunofluorescence assays combined with viral growth kinetics and reporter gene stability assessments indicated that rL251-ORF4-5a-EGFP maintained relatively stable expression during serial passage, and viral titers at 72 hours post-infection (hpi) were comparable to the parental virus. Subsequently, we identified four candidate compounds with potential anti-PRRSV activity using rPRRSV-L251-ORF4-5a-EGFP, indicating that this platform can be used as a visual assessment tool for antiviral drug screening. This study demonstrated that the ORF4-5a interval region is a feasible and promising site for exogenous gene insertion, and provided a robust technical platform for PRRSV vaccine development and pathogenesis studies.

Keywords: PPPSV1, BAC2, EGFP3, antiviral drug screening4, reverse genetics system5

Received: 24 Jun 2025; Accepted: 26 Jul 2025.

Copyright: © 2025 Liu, Fu, Yukun, Liu, Benjin, Lingzhi, Wei, Xiumei and Cui. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Yang Wei, Northeast Agricultural University, Harbin, China
Dong Xiumei, Northeast Agricultural University, Harbin, China
Jin Cui, Northeast Agricultural University, Harbin, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.